Clinical Trial to Compare the Pharmacokinetics of DP-R208
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
A randomized, single-dose, open, crossover clinical trial to compare the pharmacokinetics of
DP-R208 (Candesartan cilexetil and Rosuvastatin calcium fixed dose combinations) in
comparison to each component administered alone in healthy male volunteers